<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">Consequently, recent retrospective studies suggest that US-guided central venous cannulation can safely be performed in patients with a platelet count above 20 Ã— 10 
 <sup>9</sup>/L [
 <xref ref-type="bibr" rid="CR28">28</xref>, 
 <xref ref-type="bibr" rid="CR32">32</xref>, 
 <xref ref-type="bibr" rid="CR33">33</xref>]. In a study with 604 CVC placements, in 193 patients with acute leukemia, manual compression to stop bleeding was required in eight patients, no major bleeding was observed [
 <xref ref-type="bibr" rid="CR28">28</xref>]. However, this study missed a control group and the administration of prophylactic platelet transfusion was not standardised, resulting in high risk of bias.
</p>
